If I were as dissatisfied with the AHZ management as you seem to...

If I were as dissatisfied with the AHZ management as you seem to be, I would definitely sell. I am also curious about why you bought the stock in the first place. Surely you would have done enough research to understand that Admedus are trying to sell a product in a competitive market to people who are traditionally very conservative when it comes trying new things. It takes time. From what I understand, it took SRX and RMD 5 years to reach 3 million revenue for their initial products. AHZ will have easily surpassed that this quarter.

For my part, I think management have done as well as could be expected. Cardiocel has been adopted by some of the world's most recognizable heart centers and implanted in over 1600 patients. Up from just over 1000 less than 3 moths ago. That is impressive growth and shows that the product is fast becoming that heart patch market's gold standard.